Cargando…

Hypoparathyroidism: Replacement Therapy with Parathyroid Hormone

Hypoparathyroidism (HypoPT) is characterized by low serum calcium levels caused by an insufficient secretion of parathyroid hormone (PTH). Despite normalization of serum calcium levels by treatment with activated vitamin D analogues and calcium supplementation, patients are suffering from impaired q...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rejnmark, Lars, Underbjerg, Line, Sikjaer, Tanja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722396/ https://www.ncbi.nlm.nih.gov/pubmed/26394728 http://dx.doi.org/10.3803/EnM.2015.30.4.436

Ejemplares similares

Therapy of Hypoparathyroidism by Replacement with Parathyroid Hormone
por: Rejnmark, Lars, et al.
Publicado: (2014)

Dental Findings in Patients With Non-surgical Hypoparathyroidism and Pseudohypoparathyroidism: A Systematic Review
por: Hejlesen, Jane, et al.
Publicado: (2018)

Changes in treatment needs for chronic postoperative hypoparathyroidism during initiation of conventional treatment compared to stable phase of treatment
por: Storm, Pernille, et al.
Publicado: (2021)

Dental anomalies and orthodontic characteristics in patients with pseudohypoparathyroidism
por: Hejlesen, Jane, et al.
Publicado: (2019)

Correlations Between Changes in Undercarboxylated Osteocalcin and Muscle Function in Hypoparathyroidism
por: Harslof, Torben, et al.
Publicado: (2016)

Epidemiology and Financial Burden of Adult Chronic Hypoparathyroidism
por: Bjornsdottir, Sigridur, et al.
Publicado: (2022)

Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26‐Week Results From the Phase 3 PaTHway Trial
por: Khan, Aliya A, et al.
Publicado: (2022)

A Phase I Randomized Trial of Once‐Daily Versus Twice‐Daily Recombinant Human Parathyroid Hormone (1‐84) for Hypoparathyroidism
por: Ing, Steven W., et al.
Publicado: (2023)

Bone Indices in Thyroidectomized Patients on Long-Term Substitution Therapy with Levothyroxine Assessed by DXA and HR-pQCT
por: Moser, Emil, et al.
Publicado: (2015)

Parathyroid Hormone Replacement versus Oral Calcium and Active Vitamin D Supplementation in Hypoparathyroidism: A Meta-analysis
por: Palui, Rajan, et al.
Publicado: (2020)

Renal complications in patients with chronic hypoparathyroidism on conventional therapy: a systematic literature review: Renal disease in chronic hypoparathyroidism
por: Gosmanova, Elvira O., et al.
Publicado: (2021)

Total thyroidectomy: reduction in postoperative hypoparathyroidism
por: Reinke, Rasmus, et al.
Publicado: (2023)

Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism
por: Mannstadt, Michael, et al.
Publicado: (2019)

Effects of parathyroid hormone rhPTH(1–84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study
por: Clarke, Bart L., et al.
Publicado: (2016)

Association between Decreased Serum Parathyroid Hormone after Total Thyroidectomy and Persistent Hypoparathyroidism
por: Wang, Jian-Biao, et al.
Publicado: (2015)

The effect of melatonin treatment on postural stability, muscle strength, and quality of life and sleep in postmenopausal women: a randomized controlled trial
por: Amstrup, Anne Kristine, et al.
Publicado: (2015)

TransCon PTH as a Hormone Replacement Therapy for Patients with Hypoparathyroidism: 6-Month Update from the PaTH Forward Open-Label Extension
por: Rubin, Mishaela R, et al.
Publicado: (2021)

Safety and Efficacy of Oral Human Parathyroid Hormone (1‐34) in Hypoparathyroidism: An Open‐Label Study
por: Ish‐Shalom, Sofia, et al.
Publicado: (2021)

Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism
por: Vokes, Tamara J, et al.
Publicado: (2017)

Postoperative Hypoparathyroidism and the Viability of the Parathyroid Glands During Thyroidectomy
por: Ji, Yong Bae, et al.
Publicado: (2017)

Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism
por: Watts, Nelson B, et al.
Publicado: (2023)

Ten-year use of recombinant parathyroid hormone for the treatment of hypoparathyroidism in a boy with partial Jacobsen syndrome
por: Dayal, Devi, et al.
Publicado: (2020)

Patients’ views about parathyroid transplantation for post-thyroidectomy hypoparathyroidism
por: Stevenson, Alexander, et al.
Publicado: (2018)

MANAGEMENT OF ENDOCRINE DISEASE: Postsurgical hypoparathyroidism: current treatments and future prospects for parathyroid allotransplantation
por: Mihai, Radu, et al.
Publicado: (2021)

Relationship between hypoparathyroidism and the number of parathyroid glands preserved during thyroidectomy
por: Song, Chang Myeon, et al.
Publicado: (2014)

Effect of autotransplantation of a parathyroid gland on hypoparathyroidism after total thyroidectomy
por: Su, Anping, et al.
Publicado: (2018)

The Relationship of Magnesium Level with the Recovery of Parathyroid Function in Post-thyroidectomy Hypoparathyroidism
por: Aygun, Nurcihan, et al.
Publicado: (2021)

Simultaneous Kidney and Parathyroid Transplantation in the Management of Genetic Hypoparathyroidism in a Child
por: Vallant, Natalie, et al.
Publicado: (2022)

Measurement of serum intact parathyroid hormone concentration 1 day after total thyroidectomy to assess risk of permanent hypoparathyroidism
por: Zheng, Jianwei, et al.
Publicado: (2020)

Parathyroid hormone of ≥1.6 pmol/L at 6 months is associated with recovery in ‘long-term’ post-surgical hypoparathyroidism
por: Arshad, Muhammad Fahad, et al.
Publicado: (2022)

Perspectives on the Search for a True Physiologic Replacement Therapy for Hypoparathyroidism
por: Winer, Karen K
Publicado: (2016)

Is it True Hypoparathyroidism? A Root Cause Analysis of Unusually Low Intact Parathyroid Hormone (iPTH) at a Clinical Laboratory
por: Ahmed, Sibtain, et al.
Publicado: (2021)

Quality of Life in Post-Surgical Hypoparathyroidism (PoSH) in Thyroid and Parathyroid Surgery
por: Hillary, Sarah L., et al.
Publicado: (2022)

SAT239 Deceased Donor Parathyroid Allotransplant For Sever Refractory Iatrogenic Hypoparathyroidism
por: Devon, Karen M, et al.
Publicado: (2023)

MON-523 Risk of Nephrolithiasis and Nephrocalcinosis in Patients with Chronic Hypoparathyroidism (HypoPT)
por: Chen, Kristina, et al.
Publicado: (2019)

Risk of Nephrolithiasis and Nephrocalcinosis in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study
por: Ketteler, Markus, et al.
Publicado: (2021)

Risk of Cardiovascular Conditions in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study
por: Gosmanova, Elvira O., et al.
Publicado: (2021)

Postoperative Hypoparathyroidism in Thyroid Surgery: Anatomic-Surgical Mapping of the Parathyroids and Implications for Thyroid Surgery
por: Burger, Florian, et al.
Publicado: (2019)

The Parathyroid Hormone-Related Protein/Parathyroid Hormone 1 Receptor Axis in Adipose Tissue
por: Izquierdo-Lahuerta, Adriana
Publicado: (2021)

Parathyroid Hormone-Related Protein/Parathyroid Hormone Receptor 1 Signaling in Cancer and Metastasis
por: Zhao, Yawei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_18jptns4lba14hoc3h2gfmprnc